Revised PORT recommendations

Schizophrenia Bulletin

Volumn 30, Issue 3, 2004, Pages 609-611

  Stroup, T Scott ^a,b   McEvoy, Joseph P ^c,d   Lieberman, Jeffrey A ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d John Umstead Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AGRANULOCYTOSIS; CLINICAL TRIAL; COGNITION; CONVALESCENCE; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE ACCESS; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; MAINTENANCE THERAPY; MENTAL HEALTH SERVICE; METABOLIC DISORDER; MYOCARDITIS; NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; SOCIAL ASPECT; SOCIAL WORK; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

EID: 10344252335     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007106     Document Type: Note

References (6)

1. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; and North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2):596-601, 2004.
2. Lehman, A.F.; Kreyenbuhl, J.; Buchanan, R.W.; Dickerson, F.B.; Dixon, L.B.; Goldberg, R.; Green-Paden, L.D.; Tenhula, W.N.; Boerescu, D.; Tek, C.; Sandson, N.; and Steinwachs, D.M. The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin, 30(2):193-217, 2004.
3. Lehman, A.F., and Steinwachs, D.M. Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin, 24(1):11-20, 1998.
4. President's New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in America. Final Report. DHHS Pub. No. SMA-03-3832. Rockville, MD: U.S. Government Printing Office, 2003.
5. Stroup, T.S.; McEvoy, J.P.; Swartz, M.S.; Byerly, M.J.; Click, I.D.; Canive, J.M.; McGee, M.F.; Simpson, G.M.; Stevens, M.C.; and Lieberman, J.A. The NIMH-CATIE project: Schizophrenia trial design and protocol development. Schizophrenia Bulletin, 29(1):15-31, 2003.
6. U.S. Food and Drug Administration. 2004 Safety Alert: Zyprexa (olanzapine). Available at http://www.fda.gov/medwatch/SAFETY/2004/zyprexa.htm. Accessed May 11, 2004.